Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • NF-κB
    (127)
  • Apoptosis
    (33)
  • COX
    (24)
  • Autophagy
    (21)
  • ERK
    (19)
  • TNF
    (18)
  • DNA/RNA Synthesis
    (17)
  • p38 MAPK
    (15)
  • JNK
    (13)
  • Others
    (102)
Filter
Search Result
Results for "

nf 1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    312
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    14
    TargetMol | Peptide_Products
  • PROTAC Products
    7
    TargetMol | PROTAC
  • Natural Products
    130
    TargetMol | Natural_Products
  • Recombinant Protein
    61
    TargetMol | Recombinant_Protein
  • Isotope Products
    7
    TargetMol | Isotope_Products
  • Antibody Products
    14
    TargetMol | Antibody_Products
  • Disease Modeling
    2
    TargetMol | Disease_Modeling_Products
  • Cell Research
    2
    TargetMol | Inhibitors_Agonists
NF-κΒ activator 1
T399652387524-59-4
NF-κΒ activator 1 can activate the nf-kappa Β gene activator, EC50 of 0.9 microns. NF-κΒ is widely used in eukaryotic cells as a gene regulating cell proliferation and cell survival. NF-κΒ activator 1 induces superoxide dismutase (SOD) 2 1 mRNA expression.
  • $87
In Stock
Size
QTY
TargetMol | Inhibitor Hot
AP-1/NF-κB activation inhibitor 1
T9656188936-12-1In house
AP-1 NF-κB activation inhibitor 1 is a potent inhibitor of AP-1 and NF-κB mediated transcriptional activation (IC50 = 1 μM), without blocking basal transcription driven by the β-actin promoter. It has a similar inhibitory effect on the production of IL-2 and IL-8 levels in stimulated cells [1].
  • $67
In Stock
Size
QTY
TLR4/NF-κB-IN-1
T203058
TLR4 NF-κB-IN-1 (Compound 7x) is an orally bioavailable inhibitor targeting the TLR4 NF-κB signaling pathway, with anti-inflammatory properties and the ability to cross the blood-brain barrier. It can alleviate LPS-induced acute neuroinflammation in mice and downregulate the protein expression of TLR4, P-NF-κB, and P-IκB-α.
  • Inquiry Price
Size
QTY
Akt/NF-κB/JNK-IN-1
T62078
Akt NF-κB JNK-IN-1 (Compound 2i) is an inhibitor of the Akt, NF-κB, and JNK signaling pathways, demonstrating inhibition of nitric oxide production (IC50: 3.15 μM) and exhibiting anti-inflammatory effects.
  • $1,520
10-14 weeks
Size
QTY
TLR4/NF-κB/MAPK-IN-1
T623592767567-26-8
TLR4 NF-κB MAPK-IN-1 is a novel antineuroinflammatory agent inhibiting the TLR4 NF-κB MAPK pathways.
  • $1,520
10-14 weeks
Size
QTY
NF-κB/PON1-IN-1
T630092419107-97-2
NF-κB PON1-IN-1 (Compound 16) is an inhibitor of the NF-κB PON1 pathway, exhibiting antioxidant activity (IC50: 45.76 μM) and hepatoprotective properties.
  • $1,520
6-8 weeks
Size
QTY
NF-κB/MAPK-IN-1
T631192413940-56-2
NF-κB MAPK-IN-1 is a potent dual inhibitor of the NF-κB and MAPK pathways with potential anti-inflammatory activity, inhibition of NO production, and inhibition of LPS-induced activation of iNOS, COX-2, ERΚ and P38. NF-κB MAPK-IN-1 is used for the prevention and treatment of rheumatoid arthritis (RA).
  • $39
In Stock
Size
QTY
Akt/NF-κB/MAPK-IN-1
T78838
Akt NF-κB MAPK-IN-1 (compound 2m) is a potent, orally active inhibitor of NO with an IC50 of 7.70 μM and low toxicity, exhibiting anti-inflammatory effects by blocking the Akt NF-κB and MAPK signaling pathways [1].
  • Inquiry Price
Size
QTY
NF-κB-IN-1
1,6-Heptadiene-3,5-dione, 1,7-bis(3,4-dimethoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methylene]-, (1E,6E)-
T91051227098-15-8
NF-κB-IN-1 (1,6-Heptadiene-3,5-dione, 1,7-bis(3,4-dimethoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methylene]-, (1E,6E)-) is a potent NF-κB signaling pathway inhibitor. It is a 4-arylidene crucumin analogue. NF-κB-IN-1 directly inhibits IKK to block NF-κB activation. NF-κB-IN-1 effectively inhibits the viability of lung cancer cells and attenuates the clonogenic activity of A549 cells.
  • $169
In Stock
Size
QTY
INF 195
INF-195, INF195
T879451211379-56-4
INF 195 is an inflammasome NLRP3 inhibitor that inhibits NLRP3-driven macrophage pyroptosis and IL-1β release. INF 195 reduces isoproterenol-induced hypertrophy in H9c2 rat myoblasts and can be used to study myocardial ischemia and myocardial infarction.
  • $33
In Stock
Size
QTY
5-Aminosalicylic Acid
Mesalazine, Mesalamine, 5-ASA
T064689-57-6
5-Aminosalicylic Acid (5-ASA) is an anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE.
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Polyphyllin VI
T6S231555916-51-3
1. Polyphyllin VI has hemostasis , expectorant , bacteriostasis, anticytotoxic, anti pregnancy kill sperm effects.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Jagged-1 (188-204) TFA(219127-21-6 free base)
Jagged-1 (188-204) TFA
TP1293
Jagged-1 (188-204) TFA(219127-21-6 free base) is a fragment of the JAG-1 protein. JAG-1 is Notch ligand, a peptide that is the most conspicuously expressed ligand in skin. JAG-1 induces epidermal maturation. Exposing submerged keratinocytes monolayers to JAG-1 with elevated calcium concentration produces stratification with loricrin expression and NF-alphaB activation.
  • $235
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Rocaglamide
Rocaglamide A, Roc-A
TQ013184573-16-0
Rocaglamide (Roc-A), isolated from the genus Aglaia, can be used to treat coughs, injuries, asthma, and inflammatory skin diseases. It is a potent inhibitor of NF-κB activation in T-cells.
  • $166
In Stock
Size
QTY
TargetMol | Inhibitor Hot
β-NF-JQ1
T105262380000-55-3In house
β-NF-JQ1 is a PROTAC that recruits aryl hydrocarbon receptor E3 (AhR E3) ligase to target proteins. Using β-NF as an AhR ligand, it targets bromodomain (BRD)-containing proteins and induces AhR and BRD protein interactions. β-NF-JQ1 exhibits potent anticancer activity associated with protein knockdown activity.
  • $44
In Stock
Size
QTY
LTβR-IN-1
T118862189366-77-4In house
LTβR-IN-1 is a potent and selective lymphin β receptor (LTβR) inhibitor with a selective inhibitory effect on the nuclear translocation of p52 of TNF12A, without affecting the nuclear translocation of p65 mediated by the TNF-α receptor. It inhibits p52 nuclear translocation stimulated by TWEAK or Anti-LTβR with an IC50 of 10 μM and regulates the NF-kB signaling pathway in a ligand-independent manner.
  • $30
In Stock
Size
QTY
Inflachromene
ICM
T24167908568-01-4In house
Inflachromene (ICM) is an inhibitor of HMGB1 and HMGB expression with anti-inflammatory activity.Inflachromene reduces seizure severity in a mouse model of epilepsy by inhibiting HMGB1 translocation, inhibits endothelial proliferation through the HMGB1 2-regulated TLR4-NF-κB pathway, and inhibits autophagy by regulating Beclin 1 activity. Inflachromene can be used to study epilepsy.
  • $117 TargetMol
In Stock
Size
QTY
INI-43
INI 43, INI43
T27612881046-01-1In house
INI-43, an inhibitor of Nuclear Import-43, shows a significant cytotoxic effect on various cervical and oesophageal cancer cell lines by targeting Kpnβ1 and interferes with the nuclear localization of Kpnβ1 and known Kpnβ1 cargoes, NFAT, NFκB, AP-1 and NF
  • $38
In Stock
Size
QTY
Hydrangenol
TN4234480-47-7In house
Hydrangenol is a natural product and can be isolated from Hydrangea serrata leaves. Hydrangenol is an antiphotoaging compound with oral activity. Hydrangenol can reduce MMP and inflammatory cytokine expression and increase moisturizing factors and antioxidant genes level, result in preventing wrinkle formation.
  • $139
In Stock
Size
QTY
Aspirin
ASA, Acetylsalicylic Acid, Acetylsalicylate
T000550-78-2
Aspirin (Acetylsalicylic Acid) is a COX inhibitor that inhibits COX1 and COX2 (IC50=5 210 μg mL) with selective, irreversible, and oral activity. Aspirin is also a histone deacetylase inhibitor that up-regulates the cell cycle blocking protein, p21. Aspirin has a variety of activities. Aspirin has anti-inflammatory, antipyretic and analgesic, and antiplatelet aggregation activities.
  • $31
In Stock
Size
QTY
α-Lipoic Acid
Thioctic acid, DL-α-Lipoic acid, (±)-α-Lipoic acid
T02001077-28-7
α-Lipoic Acid (DL-α-Lipoic acid) an octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
  • $29
In Stock
Size
QTY
Sodium salicylate
Salicylic acid sodium salt, 2-Hydroxybenzoic acid sodium salt
T033554-21-7
Sodium salicylate (2-Hydroxybenzoic acid sodium salt), a metabolite of acetylsalicylic acid, can inhibit NF-kB and reduce oxidative stress.
  • $45
In Stock
Size
QTY
(S)-(+)-Ibuprofen
Dexibuprofen, (S)-Ibuprofen
T044851146-56-6
(S)-(+)-Ibuprofen (Dexibuprofen) , is a non-steroidal anti-inflammatory drug (NSAID), inhibiting cyclooxygenase (COX).
  • $35
In Stock
Size
QTY
Lidocaine
Lignocaine, Alphacaine, Xylocaine
T0468137-58-6
Lidocaine (Alphacaine) is an amide local anesthetic with anti-inflammatory properties in vitro and in vivo. It has this functions perhaps due to an attenuation of intracellular adhesion molecule-1 (ICAM-1), pro-inflammatory cytokines, and reduction of neutrophils influx.
  • $45
In Stock
Size
QTY